8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Dec 17, 2025 · 6mo ago · Accession 0001193125-25-322950
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Kalaris Therapeutics, Inc.
- Ticker
- KLRS
- CIK
- 1754068
- Form type
- 8-K
- Filing date
- Dec 17, 2025
- Report date
- Dec 17, 2025
- Document
- d25416d8k.htm
- Size
- 9.4 MB